REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis	Embolism, Embolism and Thrombosis, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Thromboembolism, Venous Thrombosis, cardiovascular disorder, lung disorder, neoplasm, pulmonary embolism, respiratory system disorder, thrombotic disease, vascular disorder, venous thromboembolism	Recruiting	Phase 3	2026-09-29		NCT07410117

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Regeneron Pharmaceuticals	238

20 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
American Hospital Tbilisi	Tbilisi	Georgia	1
BioResearch Partner- Hialeah Hospital	Hialeah	United States	3
Caucasus Medical Centre	Tbilisi	Georgia	7
El Paso Medical Research Institute (Medresearch Inc)	El Paso	United States	2
Helios Clinical Research	North Miami Beach	United States	1
Hyogo Cancer Center	Akashi	Japan	17
Institute of Clinical Oncology	Tbilisi	Georgia	4
JSC Evex Hospitals - Caraps Medline	Tbilisi	Georgia	3
Kagawa University Hospital	Kita-gun	Japan	11
Krystyna Kiel Oncology Center	Kutaisi	Georgia	1
Llc Todua Clinic	Tbilisi	Georgia	7
LTD Cancer Research Centre	Tbilisi	Georgia	2
LTD High Technology Hospital Medcenter	Batumi	Georgia	1
Memorial Sloan Kettering Cancer Center	New York	United States	60
National Hospital Organization Osaka National Hospital (ONH)	Chuo	Japan	1
Niigata University Medical & Dental Hospital	Niigata	Japan	14
Saitama Cancer Center	Ina-machi	Japan	1
Tbilisi State Medical University and Ingorokva High Medical Technology University Clinic	Tbilisi	Georgia	3
Tokai University Hospital	Isehara-Shi	Japan	7
Yamaguchi University Hospital	Ube	Japan	12

Clinical trials